What's new

Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2025 Positive

Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2025 Positive

Mar 11, 2025 - 13:35
 0
Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2025 Positive
Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2025 Positive
Read More

Tags:

Previous Article

At $10,000, Could This 1996 Pontiac Trans Sport Get You Excited About A Minivan?

Next Article

Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Ch...

Related Posts

Orphan designation: [4-(Methyl-1H-pyrazol-4-yl)-benzyl]-(6[7-(3-pyrrolidin-1-yl-propoxy)-imidazo[1,2-a]pyridin-3-yl]-pyrimidin-4-yl]-amine Treatment of gastrointestinal stromal tumours, 16/01/2025 Positive

Orphan designation: [4-(Methyl-1H-pyrazol-4-yl)-benzyl]...

Feb 20, 2025  0

Guideline on 5 assessment and reporting of mechanistic models used in 6 the context of model informed drug development

Guideline on 5 assessment and reporting of mechanistic ...

Feb 14, 2025  0

PSUSA/00000789/202406

PSUSA/00000789/202406

Feb 14, 2025  0